Literature DB >> 22584157

Parkinson disease: Scales to detect depression in Parkinson disease.

Anette Schrag, Albert F Leentjens.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22584157     DOI： 10.1038/nrneurol.2012.96

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

2.  A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

Authors:  J R Williams; E S Hirsch; K Anderson; A L Bush; S R Goldstein; S Grill; S Lehmann; J T Little; R L Margolis; J Palanci; G Pontone; H Weiss; P Rabins; L Marsh
Journal:  Neurology       Date:  2012-03-14       Impact factor: 9.910

3.  The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease.

Authors:  A F Leentjens; F R Verhey; R Lousberg; H Spitsbergen; F W Wilmink
Journal:  Int J Geriatr Psychiatry       Date:  2000-07       Impact factor: 3.485

4.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 5.  A systematic review of prevalence studies of depression in Parkinson's disease.

Authors:  Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

6.  Recognition and treatment of depression in Parkinson's disease.

Authors:  Daniel Weintraub; Paul J Moberg; John E Duda; Ira R Katz; Matthew B Stern
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-09       Impact factor: 2.680

7.  Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.

Authors:  Daniel Weintraub; Katherine A Oehlberg; Ira R Katz; Matthew B Stern
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

8.  The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease.

Authors:  Federica Mondolo; Marjan Jahanshahi; Alessia Granà; Emanuele Biasutti; Emanuela Cacciatori; Paolo Di Benedetto
Journal:  Behav Neurol       Date:  2006       Impact factor: 3.342
  8 in total
  4 in total

Review 1.  Detecting depression in Parkinson disease: A systematic review and meta-analysis.

Authors:  Zahra Goodarzi; Kelly J Mrklas; Derek J Roberts; Nathalie Jette; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

2.  Methylphenidate : a treatment for Parkinson's disease?

Authors:  David Devos; Caroline Moreau; Arnaud Delval; Kathy Dujardin; Luc Defebvre; Regis Bordet
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

3.  Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease.

Authors:  Olga Lopatina; Toru Yoshihara; Tomoko Nishimura; Jing Zhong; Shirin Akther; Azam A K M Fakhrul; Mingkun Liang; Chiharu Higashida; Kohei Sumi; Kazumi Furuhara; Yuki Inahata; Jian-Jung Huang; Keita Koizumi; Shigeru Yokoyama; Takahiro Tsuji; Yulia Petugina; Andrei Sumarokov; Alla B Salmina; Koji Hashida; Yasuko Kitao; Osamu Hori; Masahide Asano; Yoji Kitamura; Takashi Kozaka; Kazuhiro Shiba; Fangfang Zhong; Min-Jue Xie; Makoto Sato; Katsuhiko Ishihara; Haruhiro Higashida
Journal:  Front Behav Neurosci       Date:  2014-04-22       Impact factor: 3.558

Review 4.  Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.

Authors:  Zahra Goodarzi; Bria Mele; Selynne Guo; Heather Hanson; Nathalie Jette; Scott Patten; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  BMC Neurol       Date:  2016-11-25       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.